Serum C1q Levels Have Prognostic Value for Sepsis and are Related to the Severity of Sepsis and Organ Damage

References

• Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318(13):1241–1249. doi:10.1001/jama.2017.13836
   PubMed Web of Science ®Google Scholar
• Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581–614. doi:10.1016/S1473-3099(15)70112-X
   PubMed Web of Science ®Google Scholar
• Paoli CJ, Reynolds MA, Sinha M, et al. Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889–1897. doi:10.1097/CCM.0000000000003342
   PubMed Web of Science ®Google Scholar
• Battaglia F, Baldoneschi V, Meucci V, et al. Detection of canine and equine procalcitonin for sepsis diagnosis in veterinary clinic by the development of novel MIP-based SPR biosensors. Talanta. 2021;230(12):122347. doi:10.1016/j.talanta.2021.122347
   PubMedGoogle Scholar
• Gutiérrez-Pizarraya A, León-García MDC, De Juan-idígoras R, et al. Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials. Expert Rev Anti Infect Ther. 2021;13(4):1–10. doi:10.1080/14787210.2021.1932462
   Google Scholar
• Honore PM, Redant S, Kaefer K, et al. Procalcitonin is useful for antibiotic deescalation in sepsis and septic shock: beware of some confounder! Crit Care Med. 2021;49(6):e659. doi:10.1097/CCM.0000000000004934
   PubMed Web of Science ®Google Scholar
• Qiu P, Zhou J, Zhang J, et al. Exosome: the regulator of the immune system in Sepsis. Front Pharmacol. 2021;12(10):671164. doi:10.3389/fphar.2021.671164
   PubMedGoogle Scholar
• Singla S, Machado RF. Death of the endothelium in sepsis: understanding the crime scene. Am J Respir Cell Mol Biol. 2018;59(1):3–4. doi:10.1165/rcmb.2018-0051ED
   PubMed Web of Science ®Google Scholar
• Abe T, Kubo K, Izumoto S, et al. Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation. Shock. 2020;54(2):198–204. doi:10.1097/SHK.0000000000001504
   PubMed Web of Science ®Google Scholar
• Xie Z, Shao B, Hoover C, et al. Monocyte upregulation of podoplanin during early sepsis induces complement inhibitor release to protect liver function. JCI Insight. 2020;5(13):e134749. doi:10.1172/jci.insight.134749
   PubMed Web of Science ®Google Scholar
• Müller-Redetzky H, Kellermann U, Wienhold SM, et al. Neutralizing complement C5a protects mice with pneumococcal pulmonary sepsis. Anesthesiology. 2020;132(4):795–807. doi:10.1097/ALN.0000000000003149
   PubMed Web of Science ®Google Scholar
• Li H, Chen J, Hu Y, et al. Elevated serum C1q levels in children with sepsis. Front Pediatr. 2021;9(3):619899. doi:10.3389/fped.2021.619899
   PubMedGoogle Scholar
• Yang J, Lin P, Yang M, et al. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma. Genome Biol. 2021;22(1):4. doi:10.1186/s13059-020-02222-w
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Hosszu KH, Peerschke EI. C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol. 2017;84(9):26–33. doi:10.1016/j.molimm.2016.11.003
   PubMedGoogle Scholar
• Yin C, Ackermann S, Ma Z, et al. Publisher correction: apoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25(3):529. doi:10.1038/s41591-019-0378-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding Y, Fan B, et al. Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. J Control Release. 2020;321(10):463–474. doi:10.1016/j.jconrel.2020.02.030
   PubMedGoogle Scholar
• Rawish E, Sauter M, Sauter R, et al. Complement, inflammation and thrombosis. Br J Pharmacol. 2021. doi:10.1111/bph.15476
   PubMed Web of Science ®Google Scholar
• Chen L, Zhao Y, Lai D, et al. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis. 2018;9(6):597. doi:10.1038/s41419-018-0538-5
   PubMedGoogle Scholar
• Yuan Y, Yan D, Han G, et al. Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis: a prospective pilot study. J Crit Care. 2013;28(6):1032–1038. doi:10.1016/j.jcrc.2013.09.007
   PubMed Web of Science ®Google Scholar
• Miller EC, Chase NM, Densen P, et al. Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited. Clin Immunol. 2012;145(3):241–250. doi:10.1016/j.clim.2012.09.007
   PubMed Web of Science ®Google Scholar
• Thielens NM, Tedesco F, Bohlson SS, et al. C1q: a fresh look upon an old molecule. Mol Immunol. 2017;89(12):73–83. doi:10.1016/j.molimm.2017.05.025
   PubMedGoogle Scholar
• Jin Y, Xue J, Ruan M, et al. Expression of Serum miR-155 in children with mycoplasma pneumoniae pneumonia and its role in immunity to Mycoplasma pneumoniae. Infect Drug Resist. 2021;14(9):1273–1281. doi:10.2147/IDR.S273423
   PubMedGoogle Scholar
• Gupta R, Gant VA, Williams B, et al. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms. Int J Infect Dis. 2020;99(21):381–385. doi:10.1016/j.ijid.2020.08.004
   PubMedGoogle Scholar
• Pont S, Fraikin N, Caspar Y, et al. Bacterial behavior in human blood reveals complement evaders with some persister-like features. PLoS Pathog. 2020;16(12):e1008893. doi:10.1371/journal.ppat.1008893
   PubMed Web of Science ®Google Scholar
• Held K, Thiel S, Loos M, et al. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol Immunol. 2008;45(15):3934–3941. doi:10.1016/j.molimm.2008.06.021
   PubMed Web of Science ®Google Scholar
• Li Q, Lu Q, Zhu MQ, et al. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure. BMC Gastroenterol. 2020;20(1):106. doi:10.1186/s12876-020-01258-3
   PubMed Web of Science ®Google Scholar
• Tang Y, Sun J, Pan H, et al. Aberrant cytokine expression in COVID-19 patients: associations between cytokines and disease severity. Cytokine. 2021;143(17):155523. doi:10.1016/j.cyto.2021.155523
   PubMedGoogle Scholar
• Cheng TH, Puskarich M, Li X, et al. Circulating complement C3-alpha chain levels predict survival of septic shock patients. Shock. 2020;54(2):190–197. doi:10.1097/SHK.0000000000001502
   PubMed Web of Science ®Google Scholar
• Bao D, Zhang C, Li L, et al. Integrative analysis of complement system to prognosis and immune infiltrating in colon cancer and gastric cancer. Front Oncol. 2021;10(21):553297. doi:10.3389/fonc.2020.553297
   PubMedGoogle Scholar
• Garred P, Tenner AJ, Mollnes TE. Therapeutic targeting of the complement system: from rare diseases to pandemics. Pharmacol Rev. 2021;73(2):792–827. doi:10.1124/pharmrev.120.000072
   PubMed Web of Science ®Google Scholar
• Hillmen P, Szer J, Weitz I, et al. Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2021;384(11):1028–1037. doi:10.1056/NEJMoa2029073
   PubMed Web of Science ®Google Scholar
• Brodsky RA. Eculizumab and aHUS: to stop or not. Blood. 2021;137(18):2419–2420. doi:10.1182/blood.2020010234
   PubMed Web of Science ®Google Scholar
• Pugh D, O’Sullivan ED, Duthie FA, et al. Interventions for atypical haemolytic uraemic syndrome. Cochrane Database Syst Rev. 2021;3(3):CD012862. doi:10.1002/14651858.CD012862.pub2
   PubMedGoogle Scholar
• Howard JF Jr, Vissing J, Gilhus NE, et al. Zilucoplan: an investigational complement C5 inhibitor for the treatment of acetylcholine receptor autoantibody-positive generalized myasthenia gravis. Expert Opin Investig Drugs. 2021;5(19):1–11. doi:10.1080/13543784.2021.1897567
   Google Scholar
• Cognard N, Gautier-Vargas G, Perrin P, et al. COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report. J Nephrol. 2021;13(4):1–4. doi:10.1007/s40620-021-01057-3
   Google Scholar
• Gabarin RS, Li M, Zimmel PA, et al. Intracellular and extracellular lipopolysaccharide signaling in sepsis: avenues for novel therapeutic strategies. J Innate Immun. 2021;12(9):1–10. doi:10.1159/000515740
   Google Scholar
• Dewitte A, Lepreux S, Villeneuve J, et al. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critically [corrected] ill patients? Ann Intensive Care. 2017;7(1):115. doi:10.1186/s13613-017-0337-7
   PubMedGoogle Scholar
• Ehrnthaller C, Ignatius A, Gebhard F, et al. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 2011;17(3–4):317–329. doi:10.2119/molmed.2010.00149
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou K, Ricklin D, Ward PA, et al. Interactions between coagulation and complement–their role in inflammation. Semin Immunopathol. 2012;34(1):151–165. doi:10.1007/s00281-011-0280-x
   PubMed Web of Science ®Google Scholar
• Cabral L, Fernandes M, Marques S, et al. PCT kinetics in the first week postburn for sepsis diagnosis and death prognosis-an accuracy study. J Burn Care Res. 2021;42(3):545–554. doi:10.1093/jbcr/iraa199
   PubMed Web of Science ®Google Scholar
• Spoto S, Cella E, de Cesaris M, et al. Procalcitonin and MR-proadrenomedullin combination with SOFA and qSOFA scores for sepsis diagnosis and prognosis: a diagnostic algorithm. Shock. 2018;50(1):44–52. doi:10.1097/SHK.0000000000001023
   PubMed Web of Science ®Google Scholar